There is not enough vaccine for all eligible individuals in Phases 1A and 1B to receive the COVID-19 vaccine at this time. Please check back often for updates and available appointments. The appointment schedule will be updated every Monday between 5pm and 6pm.
Are you in Phase 1A or 1B? Schedule your COVID-19 vaccinations now!
*The scheduler will be updated each Monday between 5pm - 6pm with new appointments.
The COVID-19 vaccine should be administered a minimum of 14 days before or after other vaccinations
Persons with current or prior history of COVID-19 infection
Trials indicate the mRNA COVID-19 vaccines are safe for persons with evidence of a prior COVID-19 infection
Vaccinations should be offered regardless of history of prior symptomatic or asymptomatic infection
Vaccination of persons with current COVID-19 infection should be deferred until recovery from the acute illness and
have been met to discontinue isolation
Persons with a known COVID-19 exposure
should not seek vaccination until their quarantine period has ended
Residents with a known COVID-19 exposure living in congregate healthcare settings (e.g., long-term care facilities), where exposure and transmission of SARS-CoV-2 can occur repeatedly for long periods of time, may be vaccinated
Residents of other congregate settings (e.g., correctional and detention facilities, homeless shelters) with a known COVID-19 exposure may also be vaccinated
Persons who previously received passive antibody therapy
Based on current evidence, reinfection is uncommon in the 90 days after initial infection
Vaccination should be deferred for at least 90 days as a precautionary measure
The CDC recommends 15 minute observation period following COVID-19 vaccinations
For those with a history of anaphylaxis, a 30 minute observation period is recommended
Vaccination during Pregnancy & Lactation
COVID-19 mRNA vaccinations were not tested on pregnant or lactating persons; there is no safety data available for these groups
A lactating person who is part of a group recommended to receive a COVID-19 vaccine (e.g., healthcare personnel) may choose to be vaccinated
If pregnant people are part of a group that is recommended to receive a COVID-19 vaccine (e.g., healthcare personnel), they may choose to be vaccinated.
A conversation between the patient and their clinical team may assist with decisions regarding the use of a mRNA COVID-19 vaccine, though a conversation with a healthcare provider is not required prior to vaccination
When making a decision, pregnant people and their healthcare providers should consider:
The level of COVID-19 community transmission
The patient’s personal risk of contracting COVID-19,
The risks of COVID-19 to the patient and potential risks to the fetus,
The efficacy of the vaccine,
The side effects of the vaccine, and
The lack of data about the vaccine during pregnancy
COVID-19 vaccinations contain no latex, egg , or gelatin: persons with allergies to these items can receive the COVID-19 mRNA vaccinations without concern
Allergic reactions not related to vaccines, injectable therapies, components of mRNA COVID-19 vaccines (including PEG), or polysorbates, such as food, pet, venom, or environmental allergies, or allergies to oral medications are NOT contraindications to vaccination with mRNA COVID-19 vaccines
We anticipate notification that COVID-19 vaccinations will be available in the coming weeks. Please complete the attached
and return it to the email address on the form. We will contact you when you can be immunized.